Wei Wang
25Patents
6h-index
97Co-inventors
72Inventor score
Filing activity: Jun 7, 1995 → May 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5703244A | Process for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compounds | Emerging Cross-Sectional Technologies | 48 | Expired |
| US5599816A | Quinolizinone type compounds | Human Necessities | 30 | Expired |
| US5945431A | Cytomegalovirus inhibiting compounds | Chemistry; Metallurgy | 25 | Expired |
| US7452907B2 | Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 19 | Active |
| US7169817B2 | Bis-aromatic alkanols | Chemistry; Metallurgy | 11 | Expired |
| US7279485B2 | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 9 | Expired |
| US5726182A | Quinolizinone type compounds | Human Necessities | 6 | Expired |
| US7521557B2 | Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods | Human Necessities | 5 | Expired |
| US7211595B2 | Farnesyltransferase inhibitors | Chemistry; Metallurgy | 4 | Expired |
| US7105556B2 | Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 4 | Expired |
| US8415386B2 | Azolopyrrolone melanin concentrating hormone receptor-1 antagonists | Human Necessities | 3 | Active |
| US11168079B2 | Alkene compounds as farnesoid x receptor modulators | Chemistry; Metallurgy | 3 | Active |
| US7323570B2 | Farnesyltransferase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8658131B2 | Compounds comprising 4-benzoylpiperidine as a sigma-1-selective ligand | Chemistry; Metallurgy | 1 | Active |
| US7951793B2 | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 1 | Active |
| US12275719B2 | Small molecule inhibitors of galectin-3 | Chemistry; Metallurgy | 0 | Active |
| US5837868A | Process for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compounds | Emerging Cross-Sectional Technologies | 0 | Expired |
| US12291522B2 | Galectin-3 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US5693813A | Process for preparation of 4H-4-oxo-quinolizine-3-carboxylic acid | Chemistry; Metallurgy | 0 | Expired |
| US10669238B2 | Irreversible bruton's tyrosine kinase inhibitor | Emerging Cross-Sectional Technologies | 0 | Active |
| US10266535B2 | Inhibitor of FLT3 kinase and use thereof | Human Necessities | 0 | Active |
| US11987564B2 | PTPRD inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10851098B2 | Azole amides and amines as alpha v integrin inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10793543B2 | Selective C-KIT kinase inhibitor | Chemistry; Metallurgy | 0 | Active |
| US9974778B2 | Substituted pyridinones as MGAT2 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.